Asia Pacific Veterinary Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Livestock Vaccines [Bovine Vaccines and Small Ruminant Vaccines], Companion Animal Vaccines [Feline Vaccines, Canine Vaccines, and Others], and Others) and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, and Others)

Name: Asia Pacific Veterinary Vaccines Market
SKU: Pharmaceuticals
Rating: 4.8 (18 reviews)

Market Introduction

APAC veterinary vaccines market is analyzed based on the five major countries such as China, Japan, India, Australia, South Korea, and the rest of APAC. The APAC region is expected to be the fastest-growing region among all other regions. The market is driven by the factors such as rising number of foods borne diseases among animals, growing awareness about animal health, and few hurdles for the approval of vaccines/drugs related to animal health. Moreover, increasing number of clinical trials and rising number of companies trying to enter markets in emerging economies like India, Southeast Asia and China, are expected to contribute to the market growth for veterinary vaccines market during the forecast period. Market growth in untapped economies and burgeoning awareness of diagnosis and treatment of variety of infectious diseases are the major factor driving the growth of the APAC veterinary vaccines market. However, stiff government rules related to usage of veterinary vaccines hinders the growth of APAC veterinary vaccines market.

In case of COVID-19, APAC is highly affected specially India. The impact of pandemic is far-reaching. Asian economies were among the earliest epicenters of the pandemic, but also considered to be more effective in controlling the spread of the virus. Powerful economies such as Japan, and South Korea felt the disruption that the pandemic has caused. Covid-19 have emerged as a challenge in the market of veterinary vaccines, it reduced the intensity of various veterinary activities across the globe. However, companies were focused on making animal health vaccines, drugs, and equipment more accessible to consumers by fortifying their supply chains and promoting these products as essential goods, which can be an interlude for the veterinary vaccines market overall. A revolutionized change occurred in the veterinary vaccines market due to the impact of the virus. The complete lockdown in various countries forbidden the transportation of raw materials and forbade service providers’ business. Due to which the operations of various companies failed; however, few companies managed to be afloat. For Instance: Even during the pandemic Virbac ensured the best possible continuity of commitments to veterinarians, farmers, and animal owners who, every day on the front line, continued their essential work to care for and raise those animals. Therefore, manufacturing of these vaccines became difficult to an extent, which directly impacted the APAC veterinary vaccines market.

Market Overview and Dynamics

The APAC veterinary vaccines market is expected to grow from US$ 2,257.78 million in 2021 to US$ 3,677.55 million by 2028; it is estimated to grow at a CAGR of 7.2% from 2021 to 2028. Animals carry hazardous bacteria, viruses, parasites, and fungi to people, resulting in illness. Such diseases are known as zoonotic diseases or zoonoses. The clinical effect of zoonotic illnesses may range from mild to severe and sometimes lead to death. Zoonotic illnesses are ubiquitous in the region. Moreover, in 2016, at least 55,000 individuals perished of rabies in the region. In the past decades, several new infectious human diseases causing viruses, such as Ebola virus, West Nile virus, Human Immunodeficiency Virus (HIV), Nipah virus, and Hantavirus infections, have evolved from animal reservoirs. Outbreaks, such as severe acute respiratory syndrome (SARS) and avian influenza, have underlined the potential of germs from animal reservoirs to adapt to human hosts. More than three-quarters of the human diseases that are new, emerging, or reemerging at the beginning of the 21st century is caused by pathogens derived from animals or products of animal origin. Over 30 novel human infections have been found in the previous three decades, and 75% of these are originated from animals. Hence, the emerging and reemerging zoonotic illnesses propel the demand for animal health. Thus, companies produce improved medications and vaccines to aid animal owners or other stakeholders to maintain the overall health of animals. Therefore, the growth in the incidence of zoonotic diseases boosts the APAC veterinary vaccines market growth.

Key Market Segments

In terms of vaccine type, the livestock vaccines segment accounted for the largest share of the APAC veterinary vaccines market in 2020. In terms of technology, the live attenuated vaccines segment held a larger market share of the APAC veterinary vaccines market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the APAC veterinary vaccines market are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are BIOVAC; Boehringer Ingelheim International GmbH; Ceva; Elanco; Hester Biosciences Limited; HIPRA; Merck & Co., Inc.; NEOGEN Corporation; Virbac; and Zoetis Inc. among others.

Reasons to buy report

To understand the APAC veterinary vaccines market landscape and identify market segments that are most likely to guarantee a strong return
Stay ahead of the race by comprehending the ever-changing competitive landscape for APAC veterinary vaccines market
Efficiently plan M&A and partnership deals in APAC veterinary vaccines market by identifying market segments with the most promising probable sales
Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form APAC veterinary vaccines market
Obtain market revenue forecast for market by various segments from 2021-2028 in APAC region.

APAC Veterinary Vaccines Market Segmentation

APAC Veterinary Vaccines Market - By Vaccine Type

Livestock Vaccines
- Bovine Vaccines
- Small Ruminant Vaccines
Companion Animal Vaccines
- Feline Vaccines
- Canine Vaccines
- Others
Others

APAC Veterinary Vaccines Market - By Technology

APAC Veterinary Vaccines Market - By Country

APAC Veterinary Vaccines Market - Company Profiles

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 APAC Veterinary Vaccines Market – By Vaccine Type

1.3.2 APAC Veterinary Vaccines Market – By Technology

1.3.3 APAC Veterinary Vaccines Market – By Country

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. APAC Veterinary Vaccines Market – Market Landscape

4.1 Overview

4.2 APAC PEST Analysis

4.3 Experts Opinion

5. APAC Veterinary Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Escalating Incidences of Zoonotic Diseases

5.1.2 Surging Prevalence of Foodborne Diseases and Infections

5.2 Market Restraints

5.2.1 Stiff Government Rules Related to Usage of Veterinary Vaccines

5.3 Market Opportunities

5.3.1 Market Growth in Untapped Economies

5.4 Future Trends

5.4.1 Burgeoning Awareness of Diagnosis and Treatment of Variety of Infectious Diseases

5.5 Impact Analysis

6. Veterinary Vaccines Market– APAC Analysis

6.1 APAC Veterinary Vaccines Market Revenue Forecast and Analysis

7. APAC Veterinary Vaccines Market Revenue and Forecasts to 2028– By Vaccine Type

7.1 Overview

7.2 APAC Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

7.3 Livestock Vaccines

7.3.1 Overview

7.3.2 Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.3 Bovine Vaccines

7.3.3.1 Overview

7.3.3.2 Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.3.4 Small Ruminant Vaccines

7.3.4.1 Overview

7.3.4.2 Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4 Companion Vaccines

7.4.1 Overview

7.4.2 Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.3 Feline Vaccines

7.4.3.1 Overview

7.4.3.2 Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.4 Canine Vaccines

7.4.4.1 Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.4.5 Other Companion Animal Vaccines

7.4.5.1 Overview

7.4.5.2 Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

7.5 Others:

7.5.1 Overview

7.5.2 Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

8. APAC Veterinary Vaccines Market Revenue and Forecasts to 2028 – By Technology

8.1 Overview

8.2 APAC Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

8.3 Live Attenuated Vaccines

8.3.1 Overview

8.3.2 Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.4 Inactivated Vaccines

8.4.1 Overview

8.4.2 Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.5 Toxoid Vaccines

8.5.1 Overview

8.5.2 Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.6 Recombinant Vaccines

8.6.1 Overview

8.6.2 Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Veterinary Vaccines Market Revenue and Forecast to 2028 (US$ Million)

9. APAC Veterinary Vaccines Market Revenue and Forecasts to 2028 – Country Analysis

9.1 APAC: Veterinary Vaccines Market

9.1.1 Overview

9.1.2 APAC: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)

9.1.2.1 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2 China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.2.1 China: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.2.1.1 China: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.2.1.2 China: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.2.2.2 China: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.2.3 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.1 Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.3.2 Japan: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.3.2.1 Japan: Veterinary Vaccines Market, by Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.3.2.2 Japan: Veterinary Vaccines Market, by Companion Vaccines, 2019–2028 (USD Million)

9.1.2.3.3 Japan: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.2.4 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.1 India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.4.2 India: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.4.2.1 India: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.4.2.2 India: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)

9.1.2.4.3 India: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.2.5 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.1 Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.5.2 Australia: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.5.2.1 Australia: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.5.2.2 Australia: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)

9.1.2.5.3 Australia: Veterinary Vaccines Market, by Technology , 2019–2028 (USD Million)

9.1.2.6 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.1 South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.6.2 South Korea: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.6.2.1 South Korea: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.6.2.2 South Korea: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)

9.1.2.6.3 South Korea: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

9.1.2.7 Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.7.1 Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

9.1.2.7.2 Rest of APAC: Veterinary Vaccines Market, By Vaccine Type, 2019–2028 (USD Million)

9.1.2.7.2.1 Rest of APAC: Veterinary Vaccines Market, By Livestock Vaccines, 2019–2028 (USD Million)

9.1.2.7.2.2 Rest of APAC: Veterinary Vaccines Market, By Companion Vaccines, 2019–2028 (USD Million)

9.1.2.7.3 Rest of APAC: Veterinary Vaccines Market, by Technology, 2019–2028 (USD Million)

10. Impact of COVID-19 Pandemic on APAC Veterinary Vaccines Market

10.1 APAC: Impact Assessment of COVID-19 Pandemic

11. Industry Landscape

11.1 Overview

11.2 Organic Developments

11.2.1 Overview

11.3 Inorganic Developments

11.3.1 Overview

12. Company Profiles

12.1 Boehringer Ingelheim International GmbH

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Zoetis Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 Merck & Co., Inc.

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Virbac

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 BIOVAC

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 NEOGEN Corporation

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 Elanco

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 HIPRA

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Ceva

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 Hester Biosciences Limited

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. APAC Veterinary Vaccines Market – Revenue, and Forecast to 2028 (US$ Million)

Table 2. China: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 3. China Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 4. China Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 5. China Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 6. Japan: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 7. Japan Veterinary Vaccines Market, by Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 8. Japan Veterinary Vaccines Market, by Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 9. Japan Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 10. India: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 11. India: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 12. India: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 13. India Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 14. Australia: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 15. Australia: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 16. Australia: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 17. Australia Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 18. South Korea: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 19. South Korea: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 20. South Korea: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 21. South Korea Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 22. Rest of APAC: Veterinary Vaccines Market, By Vaccine Type– Revenue and Forecast to 2028 (USD Million)

Table 23. Rest of APAC: Veterinary Vaccines Market, By Livestock Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 24. Rest of APAC: Veterinary Vaccines Market, By Companion Vaccines– Revenue and Forecast to 2028 (USD Million)

Table 25. Rest of APAC Veterinary Vaccines Market, by Technology– Revenue and Forecast to 2028 (USD Million)

Table 26. Organic Developments Done by Companies

Table 27. Inorganic Developments Done by Companies

Table 28. Glossary of Terms

LIST OF FIGURES

Figure 1. APAC Veterinary Vaccines Market Segmentation

Figure 2. APAC Veterinary Vaccines Market, By Country

Figure 3. APAC Veterinary Vaccines Market Overview

Figure 4. Livestock Vaccines Segment Held the Largest Share of the Market in 2021

Figure 5. India is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. APAC: PEST Analysis

Figure 7. Experts Opinion

Figure 8. Impact Analysis of Drivers and Restraints Pertaining to APAC Veterinary Vaccines Market

Figure 9. APAC Veterinary Vaccines Market – Forecast and Analysis to 2028

Figure 10. APAC Veterinary Vaccines Market, By Vaccine Type, 2021 & 2028 (%)

Figure 11. APAC Livestock Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12. APAC Bovine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13. APAC Small Ruminant Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14. APAC Companion Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15. APAC Feline Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. APAC Canine Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. APAC Other Companion Animal Vaccines: Veterinary Vaccines Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. APAC Others: Veterinary Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. APAC Veterinary Vaccines Market Share by Technology - 2021 & 2028 (%)

Figure 20. APAC Live Attenuated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 21. APAC Inactivated Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 22. APAC Toxoid Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 23. APAC Recombinant Vaccines: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 24. APAC Others: Veterinary Vaccines Market Revenue and Forecasts To 2028 (US$ Million)

Figure 25. APAC: Veterinary Vaccines Market, by Key Country – Revenue (2021) (USD Million)

Figure 26. APAC: Veterinary Vaccines Market, by Country, 2021 & 2028 (%)

Figure 27. China: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Japan: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. India: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 30. Australia: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 31. South Korea: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 32. Rest of APAC: Veterinary Vaccines Market – Revenue and Forecast to 2028 (USD Million)

Figure 33. Impact of COVID-19 Pandemic in APAC Country Markets

CONTACT US

If you have any queries about this report or would like further information, please contact us:

North America: +1 646 491 9876

Asia-Pacific: +91 20 6727 8686

Email: info@theinsightpartners.com

DISCLAIMER

No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, “The Insight Partners”.

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC veterinary vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the APAC veterinary vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the veterinary vaccines market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000